News and Announcements
Phylogica Expands Collaboration with Janssen for peptide-drug conjugates
- Published July 01, 2013 8:54AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
PERTH, AUSTRALIA: 01 July 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today the expansion of its collaboration with Janssen Biotech, Inc. (“Janssen”) to discover, develop and commercialise new classes of peptide drug conjugates derived from Phylogica’s Phylomer drug discovery platform. Phylogica has received an undisclosed payment for funding additional research associated with the expansion of the collaboration.
The agreement with Janssen was originally executed in December 2011. This expansion of the collaboration follows the successful identification of Phylomers that specifically target the tissue-type of interest and internalise a payload within the cell. This screening phase was conducted using Phylogica’s second-generation Phylomer libraries and newly developed technology to detect Phylomer conjugates that not only penetrate cells but, importantly, also deliver their payload functionally within the cell (known as ‘endosomal escape’). Phylogica has recently filed a patent application on this platform enhancement.
To read the full ASX announcement, please download the document below.
Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
Backed By Leading Investment Groups and Family Offices
